MedTrace Logo

Improving Management of Recipients of Care With HIV Viremia to Optimize Viral Suppression in Zambia: A Process and Outcome Evaluation

NCT07747987 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 548

Last updated 2026-08-05

No results posted yet for this study

Summary

The Centre for Infectious Disease Research in Zambia (CIDRZ) as an implementing partner (IP) through its Centers for Disease Control and Prevention (CDC) and President's Emergency Plan for AIDS Relief (PEPFAR)-funded programs provides technical assistance to the Zambian Ministry of Health (MOH) to support the 95-95-95 HIV care cascade targets. Following the expansion of the DSD approach to cover non-established PLHIV, the MOH, with assistance from CIDRZ piloted the introduction of viremic clinics (VCs) as a DSD model in Lusaka to manage recipients of care (ROCs) with unsuppressed viral loads. In this paper, we describe and report on the programmatic performance and outcomes of VL testing at 6 and 12-months in PLHIV on first line ART in the VC model programme in Lusaka province as well as identify the patient and healthcare workers facilitators and barriers to improve viral suppression within the VCs.

Conditions

  • HIV - Human Immunodeficiency Virus

Interventions

OTHER

additional support

Assigned specific day for high viral load recipients of care with a team of Health care providers to provide additional support and manage patients.

Sponsors & Collaborators

Principal Investigators

  • Micheal Herce, Medical Doctor, MPH · Centre for Infectious Disease Research in Zambia

  • Izukanji Sikazwe, Medical Doctor · Centre for Infectious Disease Research in Zambia

  • James Simpungwe, Medical Doctor · CDC-Zambia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07747987 on ClinicalTrials.gov